Chicago Board Options Exchange submits 19b-4 filing for Injective ETF

Uk Jin

Summary

The Chicago Board Options Exchange has reportedly submitted an official application to the SEC to launch an Injective (INJ) ETF.
It stated that the ETF is expected to be the first Injective-based product to include staking functionality.
On the same day, the Chicago Board Options Exchange also submitted pre-registration documents for a Solana (SOL) spot ETF.

The Chicago Board Options Exchange (CBOE) has officially submitted an application to the U.S. Securities and Exchange Commission (SEC) to launch an exchange-traded fund (ETF) tracking Injective (INJ).

According to the cryptocurrency-focused media outlet The Block on the 28th (local time), the Chicago Board Options Exchange filed a proposed rule change (19b-4) for Canary Capital's 'Canary Staked INJ ETF'. This product was first proposed earlier this month, and if approved, it is expected to be the first Injective-based ETF with a staking feature.

On the same day, the Chicago Board Options Exchange, together with asset manager Invesco Galaxy, also submitted pre-registration documents for a Solana (SOL) spot ETF.

INJ